Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iradimed (IRMD) Assets (2016 - 2025)

Iradimed (IRMD) has disclosed Assets for 13 consecutive years, with $108.8 million as the latest value for Q4 2025.

  • Quarterly Assets rose 10.63% to $108.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $108.8 million through Dec 2025, up 10.63% year-over-year, with the annual reading at $108.8 million for FY2025, 10.63% up from the prior year.
  • Assets for Q4 2025 was $108.8 million at Iradimed, down from $114.7 million in the prior quarter.
  • The five-year high for Assets was $114.7 million in Q3 2025, with the low at $72.2 million in Q1 2021.
  • Average Assets over 5 years is $88.1 million, with a median of $86.5 million recorded in 2022.
  • The sharpest move saw Assets rose 0.19% in 2022, then increased 21.72% in 2025.
  • Over 5 years, Assets stood at $82.9 million in 2021, then grew by 3.18% to $85.5 million in 2022, then grew by 7.77% to $92.2 million in 2023, then increased by 6.7% to $98.3 million in 2024, then rose by 10.63% to $108.8 million in 2025.
  • According to Business Quant data, Assets over the past three periods came in at $108.8 million, $114.7 million, and $106.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.